107 related articles for article (PubMed ID: 12923387)
1. A fundamental and novel insight into the pathophysiology of hypertension or just another dubious genetic association study?
Cleland SJ
J Hypertens; 2003 Sep; 21(9):1613-4. PubMed ID: 12923387
[No Abstract] [Full Text] [Related]
2. Peroxisome proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: skaraborg hypertension and diabetes project.
Ostgren CJ; Lindblad U; Melander O; Melander A; Groop L; Råstam L
J Hypertens; 2003 Sep; 21(9):1657-62. PubMed ID: 12923397
[TBL] [Abstract][Full Text] [Related]
3. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
Chuang LM; Hsiung CA; Chen YD; Ho LT; Sheu WH; Pei D; Nakatsuka CH; Cox D; Pratt RE; Lei HH; Tai TY
J Mol Med (Berl); 2001 Nov; 79(11):656-64. PubMed ID: 11715069
[TBL] [Abstract][Full Text] [Related]
4. Evidence of differing genotypic effects of PPARalpha in women and men.
Khan QH; Pontefract DE; Iyengar S; Ye S
J Med Genet; 2004 Jun; 41(6):e79. PubMed ID: 15173245
[No Abstract] [Full Text] [Related]
5. [Genetic susceptibility to diabetes and hypertension].
Ikegami H; Ogihara T
Nihon Rinsho; 2003 Jul; 61(7):1105-12. PubMed ID: 12877070
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/bgene polymorphisms are associated with essential hypertension.
Rodríguez-Esparragón FJ; Rodríguez-Pérez JC; Macías-Reyes A; Alamo-Santana F
J Hypertens; 2003 Sep; 21(9):1649-55. PubMed ID: 12923396
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic consequences of the peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism: the weight of the evidence in genetic association studies.
Florez JC
J Clin Endocrinol Metab; 2004 Sep; 89(9):4234-7. PubMed ID: 15356013
[No Abstract] [Full Text] [Related]
8. Peroxisome proliferator--activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension.
Jamshidi Y; Montgomery HE; Hense HW; Myerson SG; Torra IP; Staels B; World MJ; Doering A; Erdmann J; Hengstenberg C; Humphries SE; Schunkert H; Flavell DM
Circulation; 2002 Feb; 105(8):950-5. PubMed ID: 11864924
[TBL] [Abstract][Full Text] [Related]
9. KRAB zinc finger proteins and nuclear receptors: a possible cross-talk.
Losson R
Biol Chem; 1997 Jul; 378(7):579-81. PubMed ID: 9278136
[No Abstract] [Full Text] [Related]
10. [Generalities on PPARs, tissue distribution, regulation of expression, mutations].
Vidal H
Journ Annu Diabetol Hotel Dieu; 2001; ():1-10. PubMed ID: 11565451
[No Abstract] [Full Text] [Related]
11. Genetics of the metabolic syndrome.
Groop L
Br J Nutr; 2000 Mar; 83 Suppl 1():S39-48. PubMed ID: 10889791
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats.
Diep QN; Schiffrin EL
Hypertension; 2001 Aug; 38(2):249-54. PubMed ID: 11509485
[TBL] [Abstract][Full Text] [Related]
13. Association of peroxisome proliferator-activated receptor gamma 2 Pro-12-Ala polymorphism with endometriosis.
Dogan S; Machicao F; Wallwiener D; Haering HU; Diedrich K; Hornung D
Fertil Steril; 2004 May; 81(5):1411-3. PubMed ID: 15136115
[TBL] [Abstract][Full Text] [Related]
14. Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2.
Yoshikawa T; Brkanac Z; Dupont BR; Xing GQ; Leach RJ; Detera-Wadleigh SD
Genomics; 1996 Aug; 35(3):637-8. PubMed ID: 8812511
[No Abstract] [Full Text] [Related]
15. Becoming fat.
Lazar MA
Genes Dev; 2002 Jan; 16(1):1-5. PubMed ID: 11782439
[No Abstract] [Full Text] [Related]
16. Interactions between peroxisome proliferator-activated receptor gene polymorphism and birth length influence risk for type 2 diabetes.
Eriksson JG; Osmond C; Lindi V; Uusitupa M; Forsen T; Laakso M; Barker D
Diabetes Care; 2003 Aug; 26(8):2476-7. PubMed ID: 12882888
[No Abstract] [Full Text] [Related]
17. No influence of the PPARgamma2 Pro12Ala genotype on serum adiponectin concentrations in healthy Europeans.
Thamer C; Machicao F; Fritsche A; Stumvoll M; Häring H
Metabolism; 2003 Jun; 52(6):798; author reply 798-9. PubMed ID: 12800109
[No Abstract] [Full Text] [Related]
18. Pro12Ala polymorphism of the PPAR-gamma2 gene is related to increased levels of oxidized low-density lipoprotein (LDL) autoantibodies in patients with type 2 diabetes mellitus.
Gómez-Zumaquero JM; Morcillo S; Soriguer F; Tinahones FJ
Metabolism; 2003 Dec; 52(12):1648; author reply 1648-9. PubMed ID: 14669172
[No Abstract] [Full Text] [Related]
19. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.
Barroso I; Gurnell M; Crowley VE; Agostini M; Schwabe JW; Soos MA; Maslen GL; Williams TD; Lewis H; Schafer AJ; Chatterjee VK; O'Rahilly S
Nature; 1999 Dec 23-30; 402(6764):880-3. PubMed ID: 10622252
[TBL] [Abstract][Full Text] [Related]
20. The expression of PAX8-PPARgamma rearrangements is not specific to follicular thyroid carcinoma.
Nakabashi CC; Guimarães GS; Michaluart P; Ward LS; Cerutti JM; Maciel RM
Clin Endocrinol (Oxf); 2004 Aug; 61(2):280-2. PubMed ID: 15272927
[No Abstract] [Full Text] [Related]
[Next] [New Search]
